DNTH: Dianthus Therapeutics, Inc. Common Stock Company Profile & Statistics

Dianthus Therapeutics, Inc. Common Stock Profile

About

Dianthus Therapeutics Inc. is a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics. Dianthus Therapeutics Inc., formerly known as Magenta Therapeutics Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Marino Garcia

Headquarters

7 Times Square, 43rd Floor
New York, NY 10036, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

Dianthus Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

4.21B

Enterprise Value

4.16B

Enterprise Value/EBITDA(ttm)

-22.66

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.73K

Price to Book(mrq)

6.95

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-7973.33%

Profit Margin(ttm)

-12724.25%

Return on Equity(ttm)

-38.85%

Return on Invested Capital(ttm)

-39.20%

Return on Assets(ttm)

-36.42%

Income Statement

Revenue(ttm)

2.04M

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

2.04M

EBITDA(ttm)³

-183.67M

Net Income Available to Common(ttm)

-162.34M

Diluted EPS(ttm)

-4.10

Share Statistics

Beta (5Y Monthly)

1.56

52-Week Change

309.87%

S&P 500 52-Week Change

15.40%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

44.47M

Dividend Yield

0.00%

Float⁴

37.11M

% Held by Insiders

16.56%

% Held by Institutions

47.53%

Balance Sheet

Total Cash(mrq)

404.30M

Total Cash Per Share(mrq)

9.09

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

13.32%

Quick Ratio(mrq)

13.32%

Book Value Per Share(mrq)

11.42

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.34

Free Cash Flow(ytd)

-129.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

DNTH

Dianthus Therapeutics, Inc. Common Stock